UTMB
Drs. Niesel and Herzog Medical Discovery News - bridging the world of medical discovery and you...
HomeAbout UsRadio ShowsPodcastListener QuestionsRadio StationsContactsReliable LinksStudents
 

Radio Shows | A Drug That Could Halt MS | mp3wmawav

What do Annette Funicello, Clay Walker and Montel Williams have in common?

They're more famous than us?

That's true but unfortunately they also share something else, they all live with MS, Multiple Sclerosis. The disease can leave some people chair bound but the symptoms and severity actually vary quite a bit from person to person.

MS is one of several autoimmune diseases where the immune system attacks the body. In this case, it attacks an insulating substance called myelin which surrounds nerves in the central nervous system.

There are two kinds of MS.

The most common which involves the brain and brain stem involves acute attacks that can last days or weeks followed by symptom free periods.

Some people will then develop the chronic progressive form of MS where they gradually get worse without clear periods of attacks. This form of MS involves the spinal cord.

But researchers have made a remarkable discovery about a drug which is normally used to treat leukemia. In a study, the drug called Alemtuzumab seems to stop MS from advancing when given to patients in the early stages.

It cut their risk for getting worse by at least 65 percent compared to standard treatments.

They also suffered fewer attacks and recovered some functions they lost. Some of the damaged brain tissue may even have been repaired leaving people in this study less impaired than they were when the study started!

That is amazing!

These patients were also at least 75% less likely to have relapses when compared with patients on interleukin beta 1a, a drug now used in MS therapy.

More research is needed before Alemtuzumab can be used to treat MS.Once that happens, it will hopefully change the lives of millions around the world.

Click here to email this page to a friend.


For more information…

NHS Choices is a comprehensive information service that aims to put you in control of your healthcare and is provided the National Health Service of England. For their detailed report about the trials using Alemtuzumab to treat MS patients go
here this web site also provides additional links for more information.

A similar new reports are available
here and here.

The National Multiple Sclerosis Society is an excellent source of information about MS for patients and their families also reported on the use of Alemtuzumab to treat MS
here. However, this site provides excellent information about MS, living with MS, treatments, research and provides an online community where those with MS can connect and share their lives and lessons learned.

The Multiple Sclerosis Resource Centre (MSRC) is a proactive and innovative charity, passionately committed to supporting anyone affected by Multiple Sclerosis through access to unbiased information and advice. They provide excellent information on MS including information about the Alemtuzumab or as it is known by its other name Compath-1H clinical trials with MS patients.
For more information…

 
 

home | about us | radio shows | podcast | listener questions | radio stations | contact us | links | students | disclaimer

2006-2007 Drs. David Niesel and Norbert Herzog. All Rights Reserved.
The University of Texas Medical Branch. Please review our site policies.
Send mail to J. Junemann with questions or comments about this web site.